Global point of care
In the US, the Centers for Medicare & Medicaid Services (CMS) regulates laboratory testing, excluding research, through the Clinical Laboratory Improvement Amendments (CLIA). The CLIA program recently introduced the Individualized Quality Control Plan (IQCP) as a new quality control option for nonwaived testing.
This new approach allows laboratories to tailor a QC plan based on their unique environment and personnel, sample, reagents, and test system. We are pleased to provide you with materials to support your IQCP needs.
For more information, please see the IQCP Support Resources page.
A Leader In Rapid Point-Of-Care Diagnostics.
©2024 Abbott. All rights reserved. Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.
This website is governed by applicable U.S. laws and governmental regulations. The products and information contained herewith may not be accessible in all countries, and Abbott takes no responsibility for such information which may not comply with local country legal process, regulation, registration and usage.
Not all products are available in all regions. Check with your local representative for availability in specific markets. For in vitro diagnostic use only. For i-STAT test cartridge information and intended use, refer to individual product pages or the cartridge information (CTI/IFU) in the i-STAT Support area.
Abbott - A Leader in Rapid Point-of-Care Diagnostics.